Biography
Bogachan Sahin majored in molecular biology as an undergraduate at Princeton University. He completed his M.D. and Ph.D. training at the University of Texas Southwestern Medical Center at Dallas, where he studied motor learning, synaptic plasticity, and post-synaptic signal transduction in the striatum as a graduate student. After completing his neurology residency and stroke fellowship at Johns Hopkins University, he joined the faculty of the Department of Neurology at the University of Rochester Medical Center in 2013. He is currently serving as Chief of Neurology and Stroke Center Director at Highland Hospital and Director of the Vascular Neurology Fellowship Program in the School of Medicine and Dentistry. His clinical interests include stroke in the young, cerebral vasculopathies, and hereditary stroke disorders. His research is currently focused on mechanisms of visual recovery in stroke survivors, occult atrial fibrillation as a cause of cryptogenic stroke, and carotid revascularization in asymptomatic carotid disease.
Professional Background
Bogachan Sahin majored in molecular biology as an undergraduate at Princeton University. He completed his M.D. and Ph.D. training at the University of Texas Southwestern Medical Center at Dallas, where he studied motor learning, synaptic plasticity, and post-synaptic signal transduction in the striatum as a graduate student. After completing his neurology residency and stroke fellowship at Johns Hopkins University, he joined the faculty of the Department of Neurology at the University of Rochester Medical Center in 2013. He is currently serving as Chief of Neurology and Stroke Center Director at Highland Hospital and Director of the Vascular Neurology Fellowship Program in the School of Medicine and Dentistry. His clinical interests include stroke in the young, cerebral vasculopathies, and hereditary stroke disorders. His research is currently focused on mechanisms of visual recovery in stroke survivors, occult atrial fibrillation as a cause of cryptogenic stroke, and carotid revascularization in asymptomatic carotid disease.
Publications
Journal Articles
8/24/2022
Van Mieghem NM, Deeb GM, Søndergaard L, Grube E, Windecker S, Gada H, Mumtaz M, Olsen PS, Heiser JC, Merhi W, Kleiman NS, Chetcuti SJ, Gleason TG, Lee JS, Cheng W, Makkar RR, Crestanello J, George B, George I, Kodali S, Yakubov SJ, Serruys PW, Lange R, Piazza N, Williams MR, Oh JK, Adams DH, Li S, Reardon MJ, . "Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial." JAMA cardiology.. 2022 Aug 24; Epub 2022 Aug 24.
7/8/2022
Schneider CL, Prentiss EK, Busza A, Williams ZR, Mahon BZ, Sahin B. "FLUORESCE: A Pilot Randomized Clinical Trial of Fluoxetine for Vision Recovery After Acute Ischemic Stroke." Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.. 2022 Jul 8; Epub 2022 Jul 08.
8/28/2021
Murray KD, Uddin MN, Tivarus ME, Sahin B, Wang HZ, Singh MV, Qiu X, Wang L, Spincemaille P, Wang Y, Maggirwar SB, Zhong J, Schifitto G. "Increased risk for cerebral small vessel disease is associated with quantitative susceptibility mapping in HIV infected and uninfected individuals." NeuroImage. Clinical.. 2021 Aug 28; 32:102786. Epub 2021 Aug 28.
VIEW ALL PUBLICATIONS